natgillin/translations-raw huggingface dataset:
Yellow iron oxide (E 172)
Željezov oksid, žuti (E 172)
Yellow iron oxide (E172)
propilenglikol željezov oksid, žuti (E172)
Yellow iron oxide (E172)
Željezov oksid, žuti (E172)
Yellow iron oxide (E172) Red iron oxide (E172) Titanium dioxide (E171)
želatina, željezov oksid, žuti (E172), željezov oksid, crveni (E172), titanijev dioksid (E171).
Yellow oval biconvex, film-coated tablet debossed with “Pfizer” on one side and “100” on the other side.
Žuta, ovalna, bikonveksna, filmom obložena tableta s utisnutom oznakom "Pfizer" na jednoj strani i "100" na drugoj strani.
Yellow Plunger
Žuti klip
Yellow Plunger Visible After Injection
Žuti klip vidljiv nakon injiciranja
Yellow round flat faced radial edge tablets engraved ‘APO’ on one side and ‘OL’ over ‘10’ on the other side.
Žute, okrugle, plosnate tablete ukošenog ruba s utisnutim ”APO” na jednoj strani i ”OL” iznad ”10” na drugoj strani.
Yellow round flat faced radial edge tablets engraved ‘APO’ on one side and ‘OL’ over ‘15’ on the other side.
Žute, okrugle, plosnate tablete ukošenog ruba s utisnutim ”APO” na jednoj strani i ”OL” iznad ”15” na drugoj strani.
Yellow round flat faced radial edge tablets engraved ‘APO’ on one side and ‘OL’ over ‘20’ on the other side.
Žute, okrugle, plosnate tablete ukošenog ruba s utisnutim ”APO” na jednoj strani i ”OL” iznad ”20” na drugoj strani.
Yellow round flat faced radial edge tablets engraved ‘APO’ on one side and ‘OL’ over ‘5’ on the other side.
Žute, okrugle, plosnate tablete ukošenog ruba s utisnutim ”APO” na jednoj strani i ”OL” iznad ”5” na drugoj strani.
yellow shaft
žuti valjak,
Yellow Shaft Black
Žuti valjak
Yellow skin
žutilo kože
yellow skin (jaundice)
žuta koža (žutica)
yellow skin (jaundice)
žuta kože (žutica)
Yellow skin (jaundice)
žutilo kože (žutica)
yellow skin (jaundice) abdominal pain
žuta koža (žutica) bol u trbuhu
yellow skin (jaundice) abdominal pain.
žuta koža (žutica) bol u trbuhu
Yellow skin (jaundice) caused by abnormal liver function.
Žutilo kože (žutica) zbog oštećenja funkcije jetre.
yellow skin (jaundice) severe and life-threatening skin rashes (Stevens-Johnson syndrome/ toxic epidermal necrolysis)
žuta koža (žutica) teški i po život opasni osipi kože (Stevens-Johnsonov sindrom/toksična epidermalna nekroliza)
yellow skin (jaundice) severe and life-threatening skin rashes (Stevens-Johnson syndrome/toxic epidermal necrolysis)
žuta koža (žutica) teški i po život opasni osipi kože (Stevens-Johnsonov sindrom/toksična epidermalna nekroliza)
yellow skin (jaundice),
žuta koža (žutica),
yellow skin and eyes, nausea, loss of appetite, dark-coloured urine (signs of liver disorders)
žuta boja kože i očiju, mučnina, gubitak apetita, tamna boja mokraće (znakovi poremećaja jetre)
Yellow skin or eyes, itching or pain in the abdomen (tummy) caused by inflammation of the liver
žuta boja kože ili očiju, svrbež ili bol u trbuhu prouzročen upalom jetre
yellow skin or eyes, itching, or pain in the abdomen (stomach) caused by inflammation of the liver
žuta boja kože ili bjeloočnica, svrbež ili bolovi u trbuhu (želucu) prouzročeni upalom jetre
yellow skin or eyes, itching, or pain in the abdomen (stomach) caused by inflammation of the liver
žuta boja kože ili bjeloočnica, svrbež ili bolovi u trbuhu prouzročeni upalom jetre
yellow skin or eyes, itching, or pain in the abdomen (stomach) caused by inflammation of the liver damage to kidney tubules
žutilo kože i očiju, svrbež ili bolovi u trbuhu uzrokovani upalom jetre oštećenje bubrežnih kanalića
yellow skin or eyes, itching, or pain in the abdomen (tummy) caused by inflammation of the liver
žuta boja kože ili očiju, svrbež ili bol u trbuhu prouzročena upalom jetre
yellow skin or eyes, itching, or pain in the abdomen (tummy) caused by inflammation of the liver (hepatitis)
žutilo kože ili očiju, svrbež ili bolovi u trbuhu uzrokovani upalom jetre (hepatitis)
yellow skin or eyes, itching, or pain in the abdomen (tummy) caused by inflammation of the liver,
žutilo kože ili očiju, svrbež ili bolovi u trbuhu (abdomenu) uzrokovani upalom jetre
Yellow skin/skin discoloration, excess pigmentation of the skin, hair colour change, rash on the palms of the hands and soles of the feet, rash, dryness of the skin.
Žuta koža/promjene boje kože, pojačana pigmentacija kože, promjene boje kose, osip na dlanovima i tabanima, osip, suhoća kože.
Yellow to beige-coloured, triangular-shaped coated tablet marked “RAPAMUNE 2 mg” on one side.
Obložena tableta žute do bež boje, trokutastog oblika s oznakom „RAPAMUNE 2 mg“ s jedne strane.
Yellow to light yellow, capsule shaped tablet, debossed with "93" on one side and “211” on the other.
Žuta do svijetložuta tableta oblika kapsule, s utisnutom oznakom „93“ na jednoj strani te „211“ na drugoj strani tablete.
Yellow, almond-shaped (5 x 8.4 mm) film-coated tablet engraved with “TL” on one side and “10” on the other side.
Žuta, filmom obložena tableta, bademastog oblika (5 x 8,4 mm) s utisnutim “TL” na jednoj strani i 10” na drugoj strani.
Yellow, almond-shaped 5 x 8.4 mm film-coated tablets marked with “TL” on one side and “10” on the other side.
Žuta filmom obložena tableta bademastog oblika, 5 x 8,4 mm, s oznakom “TL” na jednoj strani i “10” na drugoj strani.
Yellow, capsule-shaped, film-coated tablet debossed with “Teva” on one side and “7541” on the other
Žuta filmom obložena tableta oblika kapsule, s utisnutom oznakom „Teva“ na jednoj i „7541“ na drugoj strani.
Yellow, convex, ovaloid tablet with a bevelled edge, with “T7” debossed on one side and “NVR” on the other.
Žuta, konveksna, ovalna tableta s kosim rubovima, s utisnutom oznakom „T7“ na jednoj i „NVR“ na drugoj strani.
Yellow, modified oval, biconvex, film-coated tablets, approximately 4.8 x 8.9 mm, with “GS” debossed on one face and “TFC” on the opposing face.
Žute, modificirano ovalne, bikonveksne, filmom obložene tablete, dimenzija približno 4,8 x 8,9 mm, s utisnutom oznakom ‘GS’ na jednoj i ‘TFC’ na suprotnoj strani.
Yellow, oblong shaped, film coated tablets, scored on one side and debossed with "9" one side of the score and with "3" on the other side of the score.
Žute, duguljaste, filmom obložene tablete s urezom na jednoj strani tablete te utisnutom oznakom „9” s jedne i „3“ s druge strane ureza.
Yellow, oblong shaped, film-coated tablets, scored on one side and debossed with "9" on one side of the score and with "3" on the other side of the score.
Žute, duguljaste, filmom obložene tablete s urezom na jednoj strani tablete te utisnutom oznakom „9” s jedne i „3“ s druge strane ureza.
Yellow, oblong, biconvex film-coated tablets.
Žute, duguljaste, bikonveksne filmom obložene tablete.
Yellow, opaque, hard gelatin capsule, size 3.
Žuta, neprozirna, tvrda želatinska kapsula, veličine 3.
Yellow, opaque, oblong (approximately 21 mm) capsule imprinted with “VYN 20” in red.
Žuta, neprozirna, duguljasta (približno 21 mm) kapsula s oznakom “VYN 20” otisnutom crvenom tintom.
Yellow, oval film-coated tablets with dimensions of 11.7 mm x 6.6 mm and debossed with ‘u50’ on one side.
Žute, ovalne, filmom obložene tablete dimenzija 11,7 mm x 6,6 mm, s utisnutom oznakom ‘u50’ na jednoj strani.
Yellow, oval, approximately 15.6 mm × 7.8 mm, biconvex film-coated tablet debossed with “AV2” on one side and “M” on the other side.
Žuta, ovalna, bikonveksna filmom obložena tableta dimenzija približno 15,6 mm × 7,8 mm s utisnutom oznakom „AV2“ na jednoj strani i „M“ na drugoj strani.
Yellow, oval, slightly biconvex, engraved with «C75» on one side and «A75» on the other side.
Žute, ovalne, blago bikonveksne tablete, s utisnutim oznakama "C75" na jednoj i "A75" na drugoj strani.
Yellow, round and biconvex tablets of 10.1 mm in diameter, engraved with “15” on one side
Žute, okrugle i bikonveksne tablete 10.1mm promjera i "15" na jednoj strani.
Yellow, round tablets debossed with 893 on one side and 2½ on the other side.
Okrugle tablete žute boje, s utisnutom oznakom 893 s jedne i 2½ s druge strane.
Yellow, round, biconvex tablets approximately 9 mm in diameter debossed with ‘SV 572’ on one side and ‘50’ on the other side.
Žute, okrugle, bikonveksne tablete, promjera približno 9 mm, s utisnutom oznakom ‘SV 572’ s jedne i ‘50’ s druge strane.
Yellow, round, debossed with “113” on one side.
Žuta, okrugla, s utisnutom oznakom "113" na jednoj strani.
Yellow, round, debossed with “223” on one side.
Žuta, okrugla, s utisnutom oznakom "223" na jednoj strani.
Yellow, round-shaped film-coated tablets (10.5 mm diameter) debossed with “DSC L60”.
Žute, okrugle filmom obložene tablete (10,5 mm u promjeru) s utisnutom oznakom “DSC L60”.
yellow, with number “1”(treatment days 1, 3 and 5; 0.25-ml syringe marking),
žuto s brojem „1“ (dani liječenja 1, 3 i 5; oznaka na štrcaljki 0,25 ml)
Yellow-coated, capsule-shaped tablet of 17.5 mm length debossed with “100” on one side.
Žuto obložena tableta u obliku kapsule, duljine 17,5 mm, s utisnutim "100" na jednoj strani.
Yellow-orange, round, biconvex tablets of 6 mm, marked with the Bayer cross on one side and 1.5 and an “R” on the other side.
Žutonarančaste, okrugle, bikonveksne tablete od 6 mm, označene Bayerovim križem s jedne strane te brojem 1.5 i slovom “R” s druge strane.
Yellow/ green suspension.
Meloxicam 0,5 mg/ml Žuta/ zelena suspenzija.
Yellow/ green suspension.
Žuto zelena suspenzija.
yellowing of skin or eyes
žutilo kože ili očiju
yellowing of the skin (jaundice)
žuta boja kože (žutica)
yellowing of the skin (jaundice)
žutilo kože (žutica)
yellowing of the skin (jaundice) liver damage
žuta boja kože (žutica) oštećenje jetre.
yellowing of the skin and eye (jaundice) collection of blood (haematoma) in the groin as a complication of the cardiac procedure where a catheter is inserted in your leg artery (pseudoaneurysm)
žuta boja kože i očiju (žutica) nakupljanje krvi (hematom) u preponama kao komplikacija postupka na srcu kod kojeg se kateter uvodi u arteriju noge (pseudoaneurizma)
yellowing of the skin and eye (jaundice) collection of blood (haematoma) in the groin as a complication of the cardiac procedure where a catheter is inserted in your leg artery (pseudoaneurysm)
žuto obojenje kože i očiju (žutica) nakupljanje krvi (hematom) u preponama kao komplikacija u srčanom postupku u kojem se uvodi kateter u arteriju noge (pseudoaneurizma)
yellowing of the skin and eye (jaundice) collection of blood (haematoma) in the groin as a complication of the cardiac procedure where a catheter is inserted in your leg artery (pseudoaneurysm)
žuto obojenje kože i očiju (žutica) nakupljanje krvi (hematom) u preponi kao komplikacija u srčanom postupku u kojem se uvodi kateter u arteriju noge (pseudoaneurizma)
yellowing of the skin and eyes (also called jaundice), or other liver disorders;
žutilo kože i očiju (poznato i kao žutica) ili drugi poremećaji jetre;
yellowing of the skin and eyes (jaundice)
žutilo kože i očiju (žutica)
Yellowing of the skin and eyes (jaundice)
žutu boju kože i očiju (žuticu)
yellowing of the skin and the eyes (jaundice)
pojava žute boje kože i očiju (žutica)
yellowing of the skin and the eyes (jaundice)
žuta boja kože i očiju (žutica)
yellowing of the skin and white part of eyes,
žuta boja kože i bjeloočnica,
Yellowing of the skin and whites of the eyes
žuta boja kože i bjeloočnica
yellowing of the skin and whites of the eyes (jaundice), or an increase in liver enzymes - these may be signs of an inflamed liver (hepatitis and hepatic failure) increased sensitivity of your skin to sunlight, sun lamps and sunbeds
žutilo kože i bjeloočnica (žutica), ili povišenje jetrenih enzima - to mogu biti znakovi upaljene jetre (hepatitis i zatajenje jetre) povećana osjetljivost kože na sunčevu svjetlost, UV lampe i solarij
yellowing of the skin and whites of the eyes (jaundice), or an increase in liver enzymes - these may be signs of an inflamed liver (hepatitis and hepatic failure). increased sensitivity of your skin to sunlight, sun lamps and sunbeds
žutilo kože i bjeloočnica (žutica), ili povišenje jetrenih enzima - to mogu biti znakovi upaljene jetre (hepatitis i zatajenje jetre) povećana osjetljivost kože na sunčevu svjetlost, UV lampe i solarij
yellowing of the skin and/or eyes (jaundice)
žuta boja kože i/ili bjeloočnica (žutica)
Yellowing of the skin and/or eyes (jaundice)
žuta boja kože i/ili očiju (žutica)
Yellowing of the skin and/or eyes (jaundice) and irregular heart beat (QTc prolongation) may occur if you or your child take too much REYATAZ.
Žutilo kože i /ili očiju (žutica) i nepravilni otkucaji srca (produženje QTc interavala) mogu se pojaviti ako Vaše dijete uzme previše lijeka REYATAZ:
Yellowing of the skin and/or eyes (jaundice) and irregular heart beat (QTc prolongation) may occur if you or your child take too much REYATAZ.
Žutilo kože i/ili očiju (žutica) i nepravilni otkucaji srca (produženje QTc intervala) mogu se pojaviti ako Vaše dijete uzme previše lijeka REYATAZ.
Yellowing of the skin and/or eyes (jaundice) and irregular heart beat (QTc prolongation) may occur if you or your child take too much REYATAZ.
Žutilo kože ili očiju (žutica) i nepravilni otkucaji srca ( produiženje QTc intervala) može nastati ako dijete uzme previše lijeka REYATAZ.
Yellowing of the skin and/or eyes (jaundice) and irregular heart beat (QTc prolongation) may occur if you or your child take too much REYATAZ.
Žutilo kože ili očiju (žutica) i nepravilni otkucaji srca (produiženje QTc intervala) mogu se pojaviti ako dijete uzme previše lijeka REYATAZ.
Yellowing of the skin and/or eyes (jaundice) and irregular heart beat (QTc prolongation) may occur if you or your child take too much REYATAZ.
Žutilo kože ili očiju (žutica) i nepravilni otkucaji srca (produiženje QTc intervala) mogu se pojaviti ako Vaše dijete uzme previše lijeka REYATAZ.
yellowing of the skin and/or eyes increased sensitivity of the skin to the sun, even in case of hazy sun, and to UV light, for instance to UV lights of a solarium change in the way the heart beats
žutilo kože i/ili očiju povećana osjetljivost kože na sunčevu svjetlost, čak i u slučaju slabog sunca, i na UV (ultraljubičastu) svjetlost, na primjer UV svjetlost solarija promjene u načinu otkucaja srca
Yellowing of the skin or the white part of the eyes
žuta boja kože ili bjeloočnica
yellowing of the skin or the whites of the eyes (jaundice) unusually dark-coloured urine
žutilo kože ili bjeloočnica (žutica) neuobičajeno taman urin
yellowing of the skin or whites of the eyes (jaundice)
pojava žutila kože ili bjeloočnica (žutica)
yellowing of the skin or whites of the eyes unusually dark urine or pale stools
žuta boja kože ili žute bjeloočnice neobično tamna mokraća ili blijeda stolica
Yellowing of the skin or whites of the eyes, caused by liver or blood problems
Žutilo kože ili bijele fleke oko očiju, izazvani problemima s jetrom ili krvi
Yellowing of the skin or whites of the eyes, caused by liver or blood problems
Žutilo kože ili bjeloočnica izazvani problemima s jetrom ili krvlju
Yellowing of the skin or whites of the eyes, caused by liver or blood problems
Žutilo kože ili bjeloočnica, izazvani problemima s jetrom ili krvi
Yellowing of your skin and eyes (jaundice), abdominal pain or swelling, nausea or vomiting, which could be symptoms of liver problems including liver failure
Žuta boja kože i očiju (žutica), bolovi u trbuhu ili oticanje trbuha, mučnina ili povraćanje, što mogu biti simptomi problema s jetrom, uključujući zatajenje jetre
Yellowing of your skin or the white part of your eyes
žuta boja kože ili bjeloočnica
Yellowing of your skin or the white part of your eyes caused by high levels of bilirrubin in your blood has been commonly reported.
Često je prijavljeno žutilo kože ili bjeloočnica koje je uzrokovano povišenim razinama bilirubina u Vašoj krvi.
Yellowing of your skin or the whites of your eyes
žutilo kože ili bjeloočnica
Yellowing of your skin or the whites of your eyes (jaundice)
Žutilo kože ili bjeloočnica (žutica)
yellowing of your skin or the whites of your eyes (jaundice)
žutilo kože i bjeloočnica (žuticu)
yellowing of your skin or the whites of your eyes (jaundice)
žutilo kože ili bjeloočnica (žutica)
yellowing of your skin or the whites of your eyes, darker urine than normal or unexplained nausea and vomiting - these may be signs of a liver problem and you will need a blood test infection - this may include flu (fever or flulike symptoms); sinus or throat infection; urine infection (urinary tract infection or cystitis); infection of the airways (bronchitis); diarrhoea or being sick (signs of gastroenteritis); cold sores (oral herpes); tooth infection; laryngitis or fungal foot infection.
žutu boju kože ili bjeloočnica, tamniju mokraću nego inače ili neobjašnjivu mučninu i povraćanje - ovo mogu biti znakovi tegoba s jetrom koji iziskuju provođenje krvnih pretraga infekciju - može uključivati gripu (vrućicu ili simptome nalik gripi); infekciju sinusa ili grla; mokraćnu infekciju (infekciju mokraćnih putova ili cistitis); infekciju dišnih putova (bronhitis); proljev ili mučninu (znakovi gastroenteritisa); groznicu (herpes usnica); infekciju zuba; laringitis ili gljivičnu infekciju stopala.
yellowish discolouration of the skin and the whites of the eyes
žućkastu boju kože i bjeloočnica
Yellox 0.9 mg/ml eye drops solution
Yellox 0,9 mg/ml kapi za oko, otopina
Yellox 0.9 mg/ml eye drops solution bromfenac
Yellox 0,9 mg/ml kapi za oko, otopina bromfenak
Yellox contains bromfenac and belongs to a group of medicines called non-steroidal anti- inflammatory drugs (NSAIDs).
Yellox sadrži bromfenak i pripada skupini lijekova koji se nazivaju nesteroidnim protuupalnim lijekovima (NSAIL).
Yellox contains sodium sulphite and benzalkonium chloride
Yellox sadrži natrijev sulfit i benzalkonijev klorid
Yellox has not been studied in patients with hepatic disease or renal impairment.
Yellox nije ispitivan u bolesnika s bolešću jetre ili oštećenjem bubrega.
Yellox should not be used in children and adolescents.
Yellox se ne smije koristiti u djece i adolescenata.
YENTREVE 20 mg hard gastro-resistant capsules
YENTREVE 20 mg tvrde želučanootporne kapsule
YENTREVE 40 mg hard gastro-resistant capsules
YENTREVE 40 mg tvrde želučanootporne kapsule
YENTREVE 40 mg hard gastro-resistant capsules YENTREVE 20 mg hard gastro-resistant capsules Duloxetine (as hydrochloride)
YENTREVE 40 mg tvrde želučanootporne kapsule YENTREVE 20 mg tvrde želučanootporne kapsule duloksetin (u obliku duloksetinklorida)
YENTREVE and Prior Continence Surgery: There are limited data that suggest that the benefits of YENTREVE are not diminished in women with stress urinary incontinence who have previously undergone continence surgery.
YENTREVE i prethodno kirurško liječenje inkontinencije: ograničeni podaci upućuju da koristi lijeka YENTREVE nisu umanjene u žena sa stresnom urinarnom inkontinencijom koje su prethodno bile podvrgnute kirurškom liječenju inkontinencije.
YENTREVE contains the active substance duloxetine.
YENTREVE sadrži djelatnu tvar duloksetin.
YENTREVE is indicated in adults.
YENTREVE je indiciran za odrasle.
YENTREVE may be associated with sedation and dizziness.
Lijek YENTREVE može biti povezan s pojavom sedacije i omaglice.
Yentreve may cause effects that you may not be aware of, such as increases in liver enzymes or blood levels of potassium, creatine phosphokinase, sugar, or cholesterol
YENTREVE može uzrokovati učinke kojih možda i niste svjesni, poput povišenja jetrenih enzima ili povišenih razina kalija, kreatin fosfokinaze, šećera ili kolesterola u krvi
YENTREVE may make you feel sleepy or dizzy.
YENTREVE može izazvati pospanost ili omaglicu.
YENTREVE must not be used in women with liver disease resulting in hepatic impairment (see sections 4.3 and 5.2).
YENTREVE se ne smije primjenjivati u žena s bolešću jetre čija je posljedica oštećenje jetrene funkcije (vidjeti dijelove 4.3 i 5.2).
YENTREVE should not be used in the treatment of children and adolescents under the age of 18 years.
YENTREVE se ne smije primjenjivati u liječenju djece i adolescenata mlađih od 18 godina.
Yeonsu-gu, Incheon 406-840 Korea
Yeonsu-gu, Incheon 406-840 Koreja
Yeonsu-gu, Incheon, 21987 Korea
Yeonsu-gu, Incheon, 21987 Koreja
Yeonsu-gu, Incheon, 406-840 Republic of Korea
Yeonsu-gu, Incheon, 406-840 Republika Koreja
YERVOY 5 mg/ml concentrate for solution for infusion
YERVOY 5 mg/ml koncentrat za otopinu za infuziju
YERVOY 5 mg/ml sterile concentrate Ipilimumab
YERVOY 5 mg/ml sterilni koncentrat ipilimumab
YERVOY acts on your immune system and may cause inflammation in parts of your body.
YERVOY djeluje na Vaš imunološki sustav i može prouzročiti upalu u nekim dijelovima tijela.
YERVOY can be used for intravenous administration either:
YERVOY se može koristiti za intravensku primjenu:
YERVOY concentrate for solution for infusion is clear to slightly opalescent, colourless to pale yellow and may contain light (few) particulates.
YERVOY koncentrat za otopinu za infuziju bistra je do lagano zamućena, bezbojna do blijedožuta tekućina i može sadržavati nešto (malo) čestica.
YERVOY has minor influence on the ability to drive and use machines.
YERVOY ima mali utjecaj na sposobnost upravljanja vozilima i rada sa strojevima.
Yervoy is a medicine that contains the active substance ipilimumab.
Yervoy je lijek koji sadrži djelatnu tvar ipilimumab.
Yervoy is commonly associated with side effects resulting from excessive activity of the immune system, including severe reactions and inflammation.
Yervoy se najčešće povezuje s nuspojavama koje su rezultat prekomjerne aktivnosti imunosnog sustava, uključujući i ozbiljne reakcije i upale.
YERVOY is for intravenous use.
Yervoy jenamijenjen za intravensku primjenu.
Yervoy is given as an infusion into a vein over 90 minutes.
Yervoy se primjenjuje intranvenskom infuzijom u trajanju od 90 minuta.
YERVOY is indicated for the treatment of advanced (unresectable or metastatic) melanoma in adults.
YERVOY je indiciran za liječenje uznapredovalog (neresektabilnog ili metastatskog) melanoma u odraslih bolesnika.
Yervoy is used to treat adults with advanced melanoma (a type of skin cancer affecting cells called melanocytes).
Yervoy se koristi za liječenje odraslih osoba s uznapredovalim melanomom (tipom raka kože koji zahvaća stanice naziva melanociti).
YERVOY should not be used in children and adolescents below 18 years of age until more information becomes available.
YERVOY se ne smije primjenjivati u djece i adolescenata mlađih od 18 godina dok se ne prikupi još informacija.
YERVOY should not be used in children and adolescents below 18 years of age.
YERVOY se ne smije primjenjivati u djece i adolescenata mlađih od 18 godina.
Yervoy was shown to improve overall survival.
Dokazano je da Yervoy poboljšava ukupno preživljenje.
YERVOY will be given to you in a hospital or clinic under the supervision of an experienced doctor.
YERVOY će Vam se davati u bolnici ili klinici pod nadzorom iskusnog liječnika.
Yes
Ne
Yes (for all three parameters listed above)
Da (za sva tri navedena parametra)
Yes 1155 0.74 [0.61;0.91]
Da 1155 0,74 [0,61;0,91]
Yes 1417 0.74 [0.63;0.87]
Da 1417 0,74 [0,63;0,87]
Yes 2732 0.76 [0.67;0.85]
Da 2732 0,76 [0,67;0,85]
Yes 3216 0.74 [0.66;0.83]
Da 3216 0,74 [0,66;0,83]
Yes 3269 0.78 [0.69;0.87]
Da 3269 0,78 [0,69;0,87]
Yes 629 0.76 [0.59;0.98]
Da 629 0,76 [0,59;0,98]
Yes 638 0.63 [0.48;0.82]
Da 638 0,63 [0,48;0,82]
Yes No
100
Yes No
analoge purina
YES NO Does the patient have prolonged QT interval at baseline (uncorrected > 440 msec)?
DA NE Ima li bolesnik produljen QT-interval na početku liječenja (nekorigirani > 440 ms)?
YES NO Does the patient have severe bradycardia, sinus node dysfunction or second and third degree heart block, in the absence of a pacemaker?
DA NE Ima li bolesnik tešku bradikardiju, poremećaj funkcije sinusnog čvora ili srčani blok drugog ili trećeg stupnja bez ugrađenog elektrostimulatora srca?
Yes, one dose between 12 and 15 months b, c
Da, jedna doza između 12 i 15 mjeseci b, c
Yes, one dose in the second year of life with an interval of at least 2 months between the primary series and booster dose c
Da, jedna doza u drugoj godini života s intervalom od najmanje 2 mjeseca između primarne serije i booster doze c
Yesc
Dac
Yields in excess of this minimum yield appear to correlate with more rapid recovery, those below with slower recovery.
Čini se da prinosi veći od ovog minimalnog prinosa koreliraju s bržim oporavkom, dok oni manji koreliraju sa sporijim oporavkom.
YMDD mutant HBV status
Status YMDD mutacije HBV